Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting1
Completed1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting125%
completed125%
not_yet_recruiting125%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingphase_2

Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway

NCT07629167
recruiting

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

NCT06633224
terminated

Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt

NCT03043339
completednot_applicable

Performances of a H. Pylori Stool PCR Test

NCT03566004

Clinical Trials (4)

Showing 4 of 4 trials
NCT07629167Phase 2

Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway

Not Yet Recruiting
NCT06633224

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

Recruiting
NCT03043339

Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt

Terminated
NCT03566004Not Applicable

Performances of a H. Pylori Stool PCR Test

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4